28 Results for "

interval

" in MedChemExpress (MCE) Product Catalog:
Products (28)

28 Results for "interval" in MCE Product Catalog:

27
27 Publications Verification
Art. -Nr.: HY-17504A
CAS. Nr.: 287714-41-4
Synonyms: ZD 4522
Rosuvastatin (ZD 4522) is a competitive HMG-CoA reductase inhibitor with an IC50 of 11 nM. Rosuvastatin potently blocks hERG current with an IC50 of 195 nM, delayed cardiac repolarization, and thereby prolonged action potential durations (APDs) and corrected QT interval (QTc) intervals. Rosuvastatin reduces the expression of the mature hERG and the interaction of heat shock protein 70 (Hsp70) with the hERG protein. Rosuvastatin effectively lowers low-density lipoprotein (LDL) cholesterol, triglycerides, and C-reactive protein levels .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-14218
CAS. Nr.: 97-39-2
Reinheit:  99.66%
Synonyms: 1,3-Di-o-tolylguanidine; DTG
Target:  

Sigma Receptor

Forschungsgebiete:  

Neurological Disease

Ditolylguanidine (1,3-Di-o-tolylguanidine) is an agonist of sigma receptor (σ1/σ2 receptor) with Ki values of 69 and 21 nM for σ1 and σ2 receptors, respectively. Ditolylguanidine effectively inhibits the growth of small cell lung cancer cells. Ditolylguanidine can be used for the research of lung cancer .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-P1604
CAS. Nr.: 60748-45-0
ATX-II is a selective sodium channel modulator toxin. ATX-II enhances late sodium current, prevents full sodium channel inactivation, and generates persistent current fractions. ATX-II has pro-arrhythmic effect. ATX-II slows intrinsic heart rate, prolongs QT interval and sinus node recovery time, and causes sinus pauses and arrests. ATX-II can be used for the research of atrial fibrillation, long QT syndrome, and long QT3 syndrome .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-P1604A
ATX-II TFA is a selective sodium channel modulator toxin. ATX-II TFA enhances late sodium current, prevents full sodium channel inactivation, and generates persistent current fractions. ATX-II TFA has pro-arrhythmic effect. ATX-II TFA slows intrinsic heart rate, prolongs QT interval and sinus node recovery time, and causes sinus pauses and arrests. ATX-II TFA can be used for the research of atrial fibrillation, long QT syndrome, and long QT3 syndrome .
loading...
    loading...
Art. -Nr.: HY-B0997
CAS. Nr.: 1435-55-8
Synonyms: Dihydroquinidine; (+)-Hydroquinidine; Hydroconquinine
Hydroquinidine (Dihydroquinidine) is a potent ion channel blocker, which exhibits strong anti-cancer activity on colon, pancreatic, and hepatocellular cancer cells. Hydroquinidine prolongs the QT interval and has antiarrhythmic efficacy .
loading...
    loading...
Art. -Nr.: HY-156794
CAS. Nr.: 2412555-70-3
Reinheit:  99.88%
Synonyms: DSP-5336
Forschungsgebiete:  

Cancer

Enzomenib (DSP-5336) is an orally active Menin inhibitor (IC50=1.4 nM, Kd=6.0 nM). Enzomenib disrupts the interaction between Menin and KMT2A/MLL fusion proteins, specifically inhibits the expression of leukemia driver genes such as HOX/MEIS1, and upregulates ITGAM. Enzomenib effectively induces cell differentiation, inhibits tumor cell proliferation, and suppresses primitive cell colony formation. Enzomenib reduces disease burden and prolongs survival, but causes adverse reactions including differentiation syndrome and QTc interval prolongation. Enzomenib is used for research on relapsed/refractory acute myeloid leukemia, acute lymphoblastic leukemia, and other hematologic malignancies with mixed lineage leukemia (MLL) rearrangements or NPM1 mutations .
loading...
    loading...
Art. -Nr.: HY-112075
CAS. Nr.: 3416-26-0
Reinheit:  98.10%
Forschungsgebiete:  

Cardiovascular Disease

Lidoflazine is a high affinity blocker of the HERG (human ether-a-go-go-related gene) K + channel. Lidoflazine is an antianginal calcium channel blocker that carries a significant risk of QT interval prolongation and ventricular arrhythmia .
loading...
    loading...
Art. -Nr.: HY-130335
CAS. Nr.: 66778-36-7
Reinheit:  99.89%
Synonyms: MJ9067
Target:  

Sodium Channel

Forschungsgebiete:  

Cardiovascular Disease

Encainide (MJ9067) is an antiarrhythmic agent with class IC activity. Encainide blocks voltage-dependent potassium channels. Encainide has the potential for life-threatening ventricular arrhythmias, symptomatic ventricular arrhythmias and supraventricular arrhythmias research .
loading...
    loading...
Art. -Nr.: HY-17504AS1
CAS. Nr.: 2070009-40-2
Synonyms: ZD 4522-d6
Rosuvastatin-d6 (ZD 4522-d6) is deuterium labeled Rosuvastatin. Rosuvastatin (ZD 4522) is a competitive HMG-CoA reductase inhibitor with an IC50 of 11 nM. Rosuvastatin potently blocks hERG current with an IC50 of 195 nM, delayed cardiac repolarization, and thereby prolonged action potential durations (APDs) and corrected QT interval (QTc) intervals. Rosuvastatin reduces the expression of the mature hERG and the interaction of heat shock protein 70 (Hsp70) with the hERG protein. Rosuvastatin effectively lowers low-density lipoprotein (LDL) cholesterol, triglycerides, and C-reactive protein levels .
loading...
    loading...
Art. -Nr.: HY-135730
CAS. Nr.: 124478-60-0
Target:  

Endogenous Metabolite

Forschungsgebiete:  

Endocrinology

Aglepristone is a synthetic steroidal antiprogestin with abortifacient activity. Aglepristone is used exclusively as an abortifacient in pregnant animals. Aglepristone has been shown to be a safe and effective abortifacient in the second trimester of pregnancy. Aglepristone causes termination of pregnancy and does not cause fetal resorption. During aglepristone treatment, an increase in plasma concentrations of prolactin was observed, while progesterone levels remained unchanged. The use of aglepristone also resulted in early arrest of corpus luteum function and a shortening of the estrus interval .
loading...
    loading...
Art. -Nr.: HY-17504AS
CAS. Nr.: 1133429-16-9
Synonyms: ZD 4522 d3
Rosuvastatin-d3 (ZD 4522-d3) is a deuterium labeled Rosuvastatin. Rosuvastatin (ZD 4522) is a competitive HMG-CoA reductase inhibitor with an IC50 of 11 nM . Rosuvastatin potently blocks human ether-a-go-go related gene (hERG) current with an IC50 of 195 nM, delayed cardiac repolarization, and thereby prolonged action potential durations (APDs) and corrected QT interval (QTc) intervals .
loading...
    loading...
Art. -Nr.: HY-W009065
CAS. Nr.: 1476-98-8
Target:  

Others

Forschungsgebiete:  

Cardiovascular Disease Cancer

Hydroquinidine hydrochloride is a potent ion channel blocker, which exhibits strong anti-cancer activity on colon, pancreatic, and hepatocellular cancer cells. Hydroquinidine hydrochloride prolongs the QT interval and has antiarrhythmic efficacy .
loading...
    loading...
Art. -Nr.: HY-105501
CAS. Nr.: 133300-00-2
Target:  

Potassium Channel

Forschungsgebiete:  

Cardiovascular Disease

KI 1769 is a potassium channel opener. KI 1769 can exhibit vasodilating effect. KI 1769 prolongs the micturition interval and reduces the resistance to fluid infusion through the urethral lumen. KI 1769 can be used for the research of cardiovascular disease .
loading...
    loading...
Art. -Nr.: HY-B0452A
CAS. Nr.: 26652-09-5
Synonyms: DU21220
Target:  

Adrenergic Receptor

Forschungsgebiete:  

Endocrinology

Ritodrine (DU21220) is a β-adrenergic agonist, also an effective smooth muscle and uterine relaxant. Ritodrine prolongs contraction interval, can be used for researching arrest premature labor .
loading...
    loading...
Art. -Nr.: HY-B0997R
CAS. Nr.: 1435-55-8
Synonyms: Dihydroquinidine (Standard); (+)-Hydroquinidine (Standard); Hydroconquinine (Standard)
Hydroquinidine (Standard) is the analytical standard of Hydroquinidine. This product is intended for research and analytical applications. Hydroquinidine (Dihydroquinidine) is a derivative of Quinidine (an antiarrhythmic agent). Hydroquinidine prolongs the QT interval and has antiarrhythmic efficacy .
loading...
    loading...
Art. -Nr.: HY-P1440A
Target:  

Potassium Channel

Forschungsgebiete:  

Neurological Disease

BeKm-1 TFA is a potent and selective KV11.1 (hERG) channel blocker. BeKm-1 TFA is selective for KV11.1 over a panel of 14 other potassium channels. BeKm-1 TFA dose-dependently prolongs QTc interval in isolated rabbit heart.
loading...
    loading...
Art. -Nr.: HY-105093
CAS. Nr.: 141696-90-4
Target:  

Adenosine Receptor

Forschungsgebiete:  

Inflammation/Immunology

N-0861 is a novel selective A1 adenosine receptor antagonist. In studies, it has been shown to be able to inhibit the negative conduction effects (prolonged AH interval) and chest pain caused by adenosine, while having no significant effect on the increase in coronary blood flow velocity caused by adenosine. This indicates that N-0861 has the property of selectively inhibiting A1 adenosine receptors .
loading...
    loading...
Art. -Nr.: HY-14218R
CAS. Nr.: 97-39-2
Synonyms: 1,3-Di-o-tolylguanidine (Standard); DTG (Standard)
Forschungsgebiete:  

Neurological Disease

Ditolylguanidine (Standard) is the analytical standard of Ditolylguanidine. This product is intended for research and analytical applications. Ditolylguanidine (1,3-Di-o-tolylguanidine) is an agonist of sigma receptor (σ1/σ2 receptor) with Ki values of 69 and 21 nM for σ1 and σ2 receptors, respectively. Ditolylguanidine effectively inhibits the growth of small cell lung cancer cells. Ditolylguanidine can be used for the research of lung cancer .
loading...
    loading...
Art. -Nr.: HY-126704
CAS. Nr.: 90961-53-8
Synonyms: KC-8857
Target:  

Potassium Channel

Forschungsgebiete:  

Cardiovascular Disease

Tedisamil (KC-8857) is an antiarrhythmic compound with important biological activities. Tedisamil exhibits a significant slowing effect on heart rate, which is achieved by inhibiting the transient outward potassium current (I(to)) in the atrium. Tedisamil inhibits multiple potassium currents, including IK, K(ATP), and PKA-activated chloride channels, thereby prolonging the cardiac action potential and QT interval, and increasing cardiac reentry. Tedisamil has antiarrhythmic effects on ventricular arrhythmias and atrial flutter in animal models .
loading...
    loading...
Art. -Nr.: HY-108998
CAS. Nr.: 96480-44-3
Forschungsgebiete:  

Cardiovascular Disease

Bisaramil hydrochloride is an antiarrhythmic compound with activity in inhibiting free radical generation. Bisaramil hydrochloride directly blocks sodium currents and exhibits enhanced sodium channel blocking ability. Bisaramil hydrochloride inhibits isoproterenol-induced slow calcium action potentials in cardiomyocytes. Bisaramil hydrochloride reduces heart rate and prolongs the PR, QRS, and QT intervals in the electrocardiogram, showing blocking effects on sodium and potassium channels. Bisaramil hydrochloride reduces cardiac conduction velocity, increases the threshold current for capture and atrial fibrillation, and prolongs the effective refractory period. Bisaramil hydrochloride reduces ventricular arrhythmias and eliminates mortality caused by ventricular fibrillation in ischemic rat hearts .
loading...
    loading...